ResMed (RMD) Tops Q4 EPS by 3c, Revenue Beats
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St rises as AI momentum holds heading into key earnings, Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts RMD Hot Sheet
Price: $250.92 -0.9%
EPS Growth %: +5.1%
Financial Fact:
Basic earnings per share: 0.54
Today's EPS Names:
OMID, SICP, SCKT, More
EPS Growth %: +5.1%
Financial Fact:
Basic earnings per share: 0.54
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q4 EPS of $0.68, $0.03 better than the analyst estimate of $0.65. Revenue for the quarter came in at $453.1 million versus the consensus estimate of $436.73 million.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- GM to offer hybrid versions of top-selling SUV models - report
- Illinois Tool Works (ITW) Tops Q3 EPS by 3c ; Offers Guidance
- Freeport-McMoran (FCX) Tops Q3 EPS by 8c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
